Homocysteine, folate enzymes and neural tube defects.
Molloy
A M
AM
Department of Clinical Medicine, Trinity College Dublin, Ireland. amolloy@tcd.ie
Weir
D G
DG
Scott
J M
JM
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D003541:Cystathionine beta-Synthase / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications; D007231:Infant, Newborn; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D009436:Neural Tube Defects / Q000209:etiology* / Q000517:prevention & control; D009751:Nutritional Requirements; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood; D014805:Vitamin B 12 / Q000502:physiology
D006710:Homocysteine; D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D003541:Cystathionine beta-Synthase; D014805:Vitamin B 12